AXSOME THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.65 USD | +1.19% |
|
+2.87% | -5.09% |
| 05/06 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
| 05/06 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 355.08Cr | - | |||||
| 9.32TCr | ||||||
| 3.96TCr | ||||||
| 3.38TCr | ||||||
| 2.68TCr | ||||||
| 1.54TCr |
